Literature DB >> 16310443

Systemic oxygen saturation and coagulation factor abnormalities before and after the fontan procedure.

Eddie W Y Cheung1, George W Chay, Edmond S K Ma, Yiu-fai Cheung.   

Abstract

Coagulation factor abnormalities are believed to predispose to increased risk for thromboembolism after the Fontan procedure. Recent data, however, suggest that coagulation abnormalities may precede the operation. This study determined coagulation factor abnormalities in patients with single-ventricle congenital heart defects before the Fontan procedure and compared the findings with age-matched post-Fontan patients and control subjects. Liver function, coagulation factor levels, and pulse oximetry readings were determined in 11 pre-Fontan patients aged 9.3+/-5.6 years. The results were compared with those of 11 age-matched post-Fontan patients, at 9.1+/-2.4 years after the Fontan procedure, and 11 age-matched controls by simple analysis of variance and post hoc Tukey's test. Liver function was normal in patients before and after surgery apart from mildly elevated bilirubin levels in post-Fontan patients (p=0.027). When compared with controls, pre-Fontan patients had significantly lower levels of protein C; protein S; antithrombin III; and factors II, V, VII, and X and longer prothrombin times (all with p<0.05). When compared with post-Fontan patients, pre-Fontan patients had similarly lower levels of free protein S (p<0.001), protein C (p=0.06), and antithrombin III (p=0.001). Systemic oxygen saturation correlated positively with the levels of anticoagulants (protein C, protein S, antithrombin III) and procoagulants (factors II, V, VII, and X) (all with p<0.05, r=0.33 to 0.61). In conclusion, the findings suggest that coagulation factor abnormalities precede the Fontan procedure and tend to normalize after the operation, relating perhaps to improved systemic oxygenation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16310443     DOI: 10.1016/j.amjcard.2005.07.074

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

Review 1.  Hypoplastic left heart syndrome: current considerations and expectations.

Authors:  Jeffrey A Feinstein; D Woodrow Benson; Anne M Dubin; Meryl S Cohen; Dawn M Maxey; William T Mahle; Elfriede Pahl; Juan Villafañe; Ami B Bhatt; Lynn F Peng; Beth Ann Johnson; Alison L Marsden; Curt J Daniels; Nancy A Rudd; Christopher A Caldarone; Kathleen A Mussatto; David L Morales; D Dunbar Ivy; J William Gaynor; James S Tweddell; Barbara J Deal; Anke K Furck; Geoffrey L Rosenthal; Richard G Ohye; Nancy S Ghanayem; John P Cheatham; Wayne Tworetzky; Gerard R Martin
Journal:  J Am Coll Cardiol       Date:  2012-01-03       Impact factor: 24.094

2.  Prospective study of the incidence and predictors of thrombus in children undergoing palliative surgery for single ventricle physiology.

Authors:  Deanna R Todd Tzanetos; Chang Yu; Marta Hernanz-Schulman; Frederick E Barr; Nancy J Brown
Journal:  Intensive Care Med       Date:  2011-10-07       Impact factor: 17.440

3.  Risk factors and serological markers of liver cirrhosis after Fontan procedure.

Authors:  Mikiko Shimizu; Kenji Miyamoto; Yunosuke Nishihara; Gaku Izumi; Shuji Sakai; Kei Inai; Toshio Nishikawa; Toshio Nakanishi
Journal:  Heart Vessels       Date:  2015-09-19       Impact factor: 2.037

4.  Cerebral hemorrhage and vasospasm in a child with congenital heart disease.

Authors:  Jessica Carpenter; Robert Keating; Steven Weinstein; Gilbert Vezina; John Berger; Michael J Bell
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

5.  Increased Risk for Thromboembolism After Fontan Surgery: Considerations for Thromboprophylaxis.

Authors:  Suelyn Van Den Helm; Christopher Noel Sparks; Vera Ignjatovic; Paul Monagle; Chantal Attard
Journal:  Front Pediatr       Date:  2022-03-28       Impact factor: 3.418

Review 6.  Venovenous Extracorporeal Life Support in Single-Ventricle Patients with Acute Respiratory Distress Syndrome.

Authors:  Alison B Nair; Peter Oishi
Journal:  Front Pediatr       Date:  2016-06-28       Impact factor: 3.418

Review 7.  Thrombosis Prevention and Anticoagulation Management in the Pediatric Patient with Congenital Heart Disease.

Authors:  Eman Abdelghani; Clifford L Cua; Jean Giver; Vilmarie Rodriguez
Journal:  Cardiol Ther       Date:  2021-06-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.